Oral rehydration composition and methods thereof
Abstract
An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preventing dehydration comprising the steps of:
a. preparing an oral rehydration composition; b. administering said oral rehydration composition to the individual; wherein said composition comprises ingredients selected from the group consisting of: water, glucose monohydrate, sodium chloride, potassium chloride, glycine, sodium dihydrogen phosphate, xantham gum, citric acid monohydrate, hydrolyzed whey protein, steviol glycoside extract, 1-glutamic acid, monosodium glutamate, and any combination thereof.
2 . The method of claim 1 , wherein said individual is a human.
3 . The method of claim 1 , wherein said individual is an animal.
4 . The method of claim 1 , wherein said subject is suffering from diarrhea.Join the waitlist — get patent alerts
Track US2019059434A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.